Showing results (331-340 of 411) with videos related to
Sort By:
Pageof 42
Cancer Research|September 15, 1988
Phase I clinical trial of carbetimerA R Hanauske, T J Melink, G S Harman, et al.Journal of the National Cancer Institute|January 16, 1991
Phase I clinical and pharmacokinetic trial of flavone acetic acidK A Havlin, J G Kuhn, J B Craig, et al.Genetics|November 27, 2019
Rapid and Predictable Evolution of Admixed Populations Between Two Drosophila Species PairsDaniel R Matute, Aaron A Comeault, Eric Earley, et al.Genetics|September 25, 2003
Heterogeneous selection at specific loci in natural environments in Arabidopsis thalianaCynthia Weinig, Lisa A Dorn, Nolan C Kane, et al.Cancer|April 15, 1990
A phase II trial of high-dose cytarabine and cisplatin in previously untreated non-small cell carcinoma of the lung. A Piedmont Oncology Association StudyD R White, B L Powell, J B Craig, et al.Selective Cancer Therapeutics|January 1, 1991
Phase I evaluation of crisnatol (BWA770U mesylate) on a monthly extended infusion scheduleP W Cobb, K A Havlin, J G Kuhn, et al.The Journal of Experimental Medicine|March 21, 1998
Interleukin 10 increases CCR5 expression and HIV infection in human monocytesS Sozzani, S Ghezzi, G Iannolo, et al.BMC Biology|December 6, 2025
Systems genetics of lifespan and senescence in Drosophila melanogasterMaryam Nasiri Aghdam, Desireé Unselt, Maria E Adonay, et al.Cancer Chemotherapy and Pharmacology|January 1, 1987
Phase I study of high-dose cytosine arabinoside and etoposide in patients with advanced malignanciesB L Powell, H B Muss, R L Capizzi, et al.Cancer Research|August 15, 1988
Phase I and clinical pharmacology trial of crisnatol (BWA770U mesylate) using a monthly single-dose scheduleG S Harman, J B Craig, J G Kuhn, et al.Pageof 42